Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States

Objective: National estimates of atherosclerotic cardiovascular disease (ASCVD) in the United States (US) are scarce, especially for patients grouped by cardiovascular risk, lipid-lowering therapy use, and low-density lipoprotein cholesterol (LDL-C) levels. The objective of this study was to estimat...

Full description

Bibliographic Details
Main Authors:	Alexa C. Klimchak, Miraj Y. Patel, Şerban R. Iorga, Natasha Kulkarni, Nathan D. Wong
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	American Journal of Preventive Cardiology
Subjects:	Atherosclerotic cardiovascular disease Lipid-lowering therapies Low-density lipoprotein cholesterol
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666667720300106

Similar Items

Erratum to ‘Lipid Treatment and Goal Attainment Characteristics among Persons with Atherosclerotic Cardiovascular Disease in the United States’ [American Journal of Preventive Cardiology 1C (2020) 100010]
by: Alexa C. Klimchak, et al.
Published: (2021-03-01)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by: Teimur Kayani, et al.
Published: (2024-03-01)

The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study
by: Zhifan Li, et al.
Published: (2024-05-01)

Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individuals from the cvMOBIUS2 registry
by: Satoshi Shoji, et al.
Published: (2025-03-01)

Triglyceride-rich lipoproteins cholesterol, 10-years atherosclerotic cardiovascular disease risk, and risk of myocardial infarction and ischemic stroke
by: Yi-Ping Jia, et al.
Published: (2024-11-01)

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
by: Michael J. Wilkinson, et al.
Published: (2023-06-01)

Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas
by: Xieda Zhou, et al.
Published: (2021-07-01)

Is it possible to regress atherosclerotic lesions with long-term treatment with lipoprotein apheresis?
by: Ulrich Julius, et al.
Published: (2024-10-01)

Age‐Related Associations of Low‐Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population‐Based Cohort Study
by: Han Na Jung, et al.
Published: (2022-05-01)

In-hospital and mid-term follow-up of low-density lipoprotein cholesterol and target-goal attainment among patients with acute cerebral infarction: a retrospective study
by: Zhong Chen, et al.
Published: (2024-02-01)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
by: Ted Okerson, et al.
Published: (2017-03-01)

Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors
by: G. R. Galstyan, et al.
Published: (2018-12-01)

Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
by: Emily Keyes, BA, et al.
Published: (2021-12-01)

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01)

Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis
by: Jing Cao, et al.
Published: (2024-11-01)

Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
by: Mohammad Alkhalil, et al.
Published: (2021-03-01)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
by: Kamil F. Faridi, et al.
Published: (2023-06-01)

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01)

An impact of lipid profile and lipid lowering drugs on ≥70 year olds of an upper socioeconomic class: a retrospective cohort study
by: Yehudit Eden Friedman, et al.
Published: (2021-09-01)

Bempedoic acid: mechanism of action and therapeutic use in atherosclerotic cardiovascular diseases and diabetes
by: V.A. Serhiyenko, et al.
Published: (2023-05-01)

Lipid and lipoprotein profiles among middle aged male smokers: a study from southern India
by: Ramachandran Meenakshisundaram, et al.
Published: (2010-10-01)

Determinants of incident atherosclerotic cardiovascular disease events among individuals with type 2 diabetic microvascular complications in the UK: a prospective cohort study
by: Yaxin Wang, et al.
Published: (2023-08-01)

Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Lawrence A. Leiter, et al.
Published: (2024-05-01)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
by: Minglu Ma, et al.
Published: (2023-03-01)

Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
by: Andrea Schwarz, et al.
Published: (2022-11-01)

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
by: Federica Galimberti, et al.
Published: (2023-09-01)

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
by: Marina Cuchel, et al.
Published: (2023-05-01)

Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
by: Peter P. Toth, MD, PhD
Published: (2021-06-01)

Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review
by: Jakub Michal Zimodro, et al.
Published: (2024-07-01)

Sex-Specific Relationships between HDL-Cholesterol Levels and 10-Year Mortality in Individuals with Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study of South Koreans
by: Hyun Suk Yang, et al.
Published: (2023-11-01)

Disorders of lipid metabolism. Clinical Guidelines 2023
by: M. V. Ezhov, et al.
Published: (2023-06-01)

Effect of mobile-based cognitive behavior therapy (CBT) on lowering of blood lipid levels in atherosclerotic cardiovascular disease (ASCVD) patients: study protocol for a multicenter, prospective, randomized controlled trial
by: Xu-Lin Hong, et al.
Published: (2022-06-01)

Lipid-Targeted Atherosclerotic Risk Reduction in Older Adults: A Review
by: Lauren J. Hassen, et al.
Published: (2022-03-01)

Modeling of Mechanical Stress Exerted by Cholesterol Crystallization on Atherosclerotic Plaques
by: Luo, Yuemei, et al.
Published: (2017)

Importance of lipid ratios for predicting intracranial atherosclerotic stenosis
by: Wen-Song Yang, et al.
Published: (2020-07-01)

Time‐Dependent Cardiovascular Treatment Benefit Model for Lipid‐Lowering Therapies
by: Irfan Khan, et al.
Published: (2020-08-01)

Contradictions in traditional ideas about atherosclerosis and the efficacy of lipid-lowering therapy. Promising directions
by: A. P. Vasiliev, et al.
Published: (2024-08-01)

Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice
by: A. I. Sapina, et al.
Published: (2025-01-01)

Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study
by: Xiangming Hu, et al.
Published: (2020-07-01)

Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11
by: Julia Truthmann, et al.
Published: (2016-03-01)